Search Results - Inge G.P. Geelen

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia by Inge G.P. Geelen, Noortje Thielen, Jeroen J.W.M. Janssen, Mels Hoogendoorn, Tanja J.A. Roosma, Sten P. Willemsen, Otto Visser, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2017-11-01)
    Get full text
    Article


  2. 2

    High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population by Camille C.B. Kockerols, Inge G.P. Geelen, Mark-David Levin, Jeroen J.W.M. Janssen, H. Berna Beveloo, Avinash G. Dinmohamed, Mels Hoogendoorn, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2023-03-01)
    Get full text
    Article


  3. 3

    Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival by Inge G.P. Geelen, Noortje Thielen, Jeroen J.W.M. Janssen, Mels Hoogendoorn, Tanja J.A. Roosma, Sten P. Willemsen, Peter J.M. Valk, Otto Visser, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2017-12-01)
    Get full text
    Article


Search Tools: